Syntis Bio develops oral therapies using a SYNT polydopamine coating to transiently alter duodenal nutrient uptake, sustain gut-restricted enzymes, and increase oral drug absorption; lead programs target obesity, metabolic disorders.
syntis.bioPart of: Boston tech scene from Fundable